---
figid: PMC9669483__fphar-13-1031804-g008
figtitle: Dexmedetomidine inhibits abnormal muscle hypertrophy of myofascial trigger
  points via TNFA/ NFKB signaling pathway in rats
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9669483
filename: fphar-13-1031804-g008.jpg
figlink: /pmc/articles/PMC9669483/figure/F8/
number: F8
caption: The proposed role of MEF2C in the inflammatory pathogenesis of MTrPs.
papertitle: Dexmedetomidine inhibits abnormal muscle hypertrophy of myofascial trigger
  points via TNF-α/ NF-κB signaling pathway in rats.
reftext: Mingjian Liu, et al. Front Pharmacol. 2022;13:1031804.
year: '2022'
doi: 10.3389/fphar.2022.1031804
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: inflammation | inflammatory hypertrophy | myocyte enhancer factor 2C | chronic
  pain | myofascial pain syndrome
automl_pathway: 0.9399601
figid_alias: PMC9669483__F8
figtype: Figure
redirect_from: /figures/PMC9669483__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9669483__fphar-13-1031804-g008.html
  '@type': Dataset
  description: The proposed role of MEF2C in the inflammatory pathogenesis of MTrPs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKB1
  - MYLK
  - MYLK2
  - MYLK3
  - MEF2C
  - MYOC
  - OOOOOO
---
